One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2020-133922
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 11 |
Affiliation: Singapore General Hospital, Duke-NUS Medical School, Jena University Hospital, St. Eugenio Hospital, Dana-Farber Cancer Institute, The University of Texas MD Anderson Cancer Center, Imperial College London, Huntsman Cancer Institute, University of Utah, Hôpital Saint-Louis, Takeda (United States), Millennium Engineering and Integration (United States), Augusta University Health, University of Bologna, Michigan Center for Translational Pathology, University of Michigan–Ann Arbor, University of Toronto, Princess Margaret Cancer Centre, Washington University in St. Louis, University of California, San Francisco, Centre Léon Bérard, Moffitt Cancer Center, Versailles Saint-Quentin-en-Yvelines University, Memorial Sloan Kettering Cancer CenterEfficacy and Safety of Ponatinib (PON) in Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Who Failed One or More Second-Generation (2G) Tyrosine Kinase Inhibitors (TKIs): Analyses Based on PACE and Optic
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
